CUSIP: 58436Q203
Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,983,555
-
Share change
-
0
-
Total reported value
-
$11,830,585
-
Price per share
-
$5.99
-
Number of holders
-
25
Quarterly Holders Quick Answers
What is CUSIP 58436Q203?
CUSIP 58436Q203 identifies MDGN - MEDGENICS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 58436Q203:
Institutional Holders of MEDGENICS INC - COM NEW (MDGN) as of Q4 2013
As of 31 Dec 2013,
MEDGENICS INC - COM NEW (MDGN) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,983,555 shares.
The largest 10 holders included
Legal & General Group Plc, Belmont Global Advisors, Inc., VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BAILLIE GIFFORD & CO, PERCEPTIVE ADVISORS LLC, LPL Financial LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock Fund Advisors.
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.